Therapeutic Oligonucleotides 2025

The second ELRIG meeting on Therapeutic Oligonucleotides, scheduled for May 14-15, 2025, will be hosted at the AstraZeneca R&D site in Gothenburg. This dynamic event aims to build upon the success of the inaugural Therapeutic Oligonucleotides meeting and the well-regarded Advances in Cell-Based Assays in Drug Discovery.

Esteemed scientists from academia, industry, and the vendor community will convene to explore the discovery, validation, and targeting of drug candidates using antisense oligonucleotides (ASOs) and siRNA. ELRIG's ambition is to establish an open-access meeting that fosters an inspiring environment for networking, encouraging collaboration between biologists and chemists across diverse research areas.